Changes in selenium levels in epilepsy;Alteración de la concentración de selenio en la epilepsia

Revista de Neurologia

Volumn 40, Issue 2, 2005, Pages 111-116

  Gutiérrez Álvarez, Ángela María ^a   Moreno, C B ^a   Gonzalez Reyes R E ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Anticonvulsants; Epilepsy; Evidence based medicine; Selenium; Trace elements

Indexed keywords

ANTICONVULSIVE AGENT; FREE RADICAL; GLUTATHIONE PEROXIDASE; SELENIUM; SELENOPROTEIN; VALPROIC ACID; PROTEIN;

BEHAVIOR; DATA BASE; EPILEPSY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NEURAL TUBE DEFECT; PRACTICE GUIDELINE; PREGNANCY; PROTEIN SYNTHESIS; REVIEW; VITAMIN SUPPLEMENTATION; BIBLIOGRAPHIC DATABASE; BLOOD; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; FEMALE; METABOLISM; OXIDATIVE STRESS;

ANTICONVULSANTS; DATABASES, BIBLIOGRAPHIC; DIETARY SUPPLEMENTS; EPILEPSY; FEMALE; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PREGNANCY; PROTEINS; SELENIUM; SELENOPROTEINS;

EID: 24344471374     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4002.2004443     Document Type: Review

References (39)

1. Pippenger CE. Pharmacology of neural tube defects. Epilepsia 2003; 44 (Suppl 3): 24-32.
2. 12 and selenium enzymes. Annu Rev Biochem 2002; 71: 1-16.
3. Pérez-Coll C. Biomarcadores de susceptibilidad a metales con énfasis en salud humana. Acta Bioquímica Clínica Latinoamericana 2001; 35: 277-85.
4. Klein EA. Selenium: epidemiology and basic science. J Urology 2004; 171: S50-S3.
5. Ortuño J, Ros G, Periago MJ, Martínez C, López G, Rodrigo J. Importancia nutricional del selenio. Arch Latinoam Nutr 1997; 47: 6-13.
6. Jaffe W. Selenio, un elemento esencial y tóxico. Datos de Latinoamérica. Arch Latinoam Nutr 1992; 42: 90-3.
7. Hill KE, Zhou J, McMahan WJ, Motley AK, Burk RF. Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J Nutrition 2004; 134: 157-61.
8. Halliwell B. Free radicals, antioxidant and human disease: curiosity, cause or consequence? Lancet 1994; 344: 721-4.
9. Vilaseca-Busca MA, Artuch-Iriberri R, Colome-Mallolas C, Brandi-Tarrau N, Campistol J, Pineda-Marfa M, et al. Alteraciones del sistema antioxidante en errores congénitos del metabolismo intermediario. Rev Neurol 2002; 34: 1021-4.
10. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-95.
11. Willmore LJ. Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia 1990; 31 (Suppl 3): S67-S73.
12. Graf WD, Oleinik OE, Glauser TA, Maertens P, Eder DN, Pippenger CE. Altered antioxidant enzime activities in children with a serious adverse experience related to valproic acid therapy. Neuropediatrics 1998; 29: 195-201.
13. Glauser T, Titanic M, Armstrong D, Pippenger C. Abnormalities in free radical scavenging enzime activity in patients with felbamate-associated aplastic anemia. Abstract. Epilepsia 1998; 39 (Suppl 2): 40.
14. Glauser TA. Idiosyncratic reactions: new methods of identifying high-risk patients. Epilepsia 2000; 41 (Suppl 8): S16-S29.
15. Wilmore LJ, Rubin JJ. Antiperoxidant pretreatment and iron-induced epileptiform discharges in the rat: EEG and histopathologic studies. Neurology 1981; 31: 63-9.
16. Remaekers VT, Calomme M, Vanden Berghe D, Makropoulos W. Selenium deficiency triggering intractable seizures. Neuropediatrics 1994; 25: 217-23.
17. Lores AS, Travacio M, Llesuy S, Rodríguez de Lores Arnaiz G. Regional vulnerability to oxidative stress in a model of experimental epilepsy. Neurochem Res 1998; 23: 1477-83.
18. Savaskan NE, Brauer AU, Kuhbacher M, Eyupoglu IY, Kyriakopoulos A, Ninnemann O, et al. Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity. Federation of American Societies for Experimental Biology 2002; 10: 1096.
19. Hirate M, Takeda A, Tamano H, Enomoto S, Oku N. Distribution of trace elements in the brain of EL (epilepsy) mice. Epilepsy Res 2002; 51: 109-16.
20. Schott GD, Delvers HT. Plasma zinc levels with anticonvulsant therapy. Br J Clin Pharmacol 1978; 5: 279-80.
21. Smith WGJ, Bone I. Copper, zinc and magnesium plasma levels in epilepsy. J Neurol Neurosurg Psychiatry 1982; 45: 1072.
22. Kaji M, Ito M, Okuno T. Serum copper and zinc levels in epileptic children with valproate treatment. Epilepsia 1992; 33: 555-7.
23. Hurd RW, Van Rinsvelt HA, Wilder BJ, Karas B, Maenhaut W, De Reu L. Selenium, zinc, and copper changes with valproic acid: possible relation to drug side effects. Neurology 1984; 34: 1393-5.
24. Committee on Drugs (AW Pruitt, chairman). Valproic acid: benefits and risks. Pediatrics 1982; 70: 316-9.
25. Weber GF, Maertens P, Meng X, Pippenger C. Glutathione peroxidase deficiency and childhood seizures. Lancet 1991; 337: 1443-4.
26. Kurekci AE, Alpay F, Tanindi S, Gokcay E, Ozcan O, Akin R, et al. Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy. Epilepsia 1995; 36: 600-4.
27. Verotti A, Basciani F, Totta D, Pomilio MP, Morgese G, Chiarelli F. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res 2002; 48: 71-5.
28. Martínez-Ballesteros C, Pita-Calandre E, Sánchez- González Y, Rodríguez-López CM, Agil A. Peroxidación lipídica en pacientes epilépticos adultos tratados con ácido valproico. Rev Neurol 2004; 38: 101-6.
29. Liu CS, Wu HM, Ko SH. Phenytoin mediated oxidative stress in serum of female epileptics: a possible pathogenesis in the fetal hydantoin syndrome. Hum Exp Toxicol 1997; 16: 177-81.
30. Muntau AC, Streiter M, Kappler M, Roschinger W, Schmid I, Rehnert A, et al. Age related reference values for serum selenium concentrations in infants and children. Clinical Chemistry 2002; 48: 555-60.
31. Shamir R, Sammour RN, Diamond E, Sohat I, Markhoul IR. Selenium concentrations in maternal and umbilical cord blood at 24-42 weeks of gestation: basis for optimisation of selenium supplementation to premature infants [abstract]. Clin Nutrition 2003; 22 (Suppl 1): S33-4.
32. Institute of Medicine, Food and Nutrition Board 2000. Dietiary reference intakes: vitamin C, vitamin E, selenium and carotenoids. Washington DC: National Academy Press; 2000.
33. Tin Win D. Selenium: atomic number 34, mass number 78.96. AU Journal of Technology 2003; 7: 1-7.
34. Harper HA. Bioquímica de Harper. 15 ed. México: Editorial Manual Moderno; 2001.
35. Abrams CK, Siram SM, Galsim C, Jonson-Hamilton H, Munford FL, Mezghebe H. Selenium deficiency in long term total parenteral nutrition. Nutr Clin Pract 1992; 7: 175-8.
36. Rannem T, Ladefoged K, Hylander E, Hegnhoj J, Staun M. Selenium depletion in patients with gastrointestinal diseases: are there any predictive factors? Scand J Gastroenterol 1998; 33: 1057-61.
37. Rannem T, Ladefoged K, Hylander E, Jarnum S. Selenium status in patients with Crohn's disease. Am J Clin Nutr 1992; 56: 933-7.
38. Bjerre B, Von Schenck H, Sorbo B. Hyposelaemia: patients with gastrointestinal disease are at risk. J Intern Med 1989; 225: 85-8.
39. Yang G, Wang S, Zhou R, Sun S. Endemic selenium intoxication of humans in China. Am J Clin Nutr 1983; 37: 872-81.